Rapport Therapeutics Stock (NASDAQ: RAPP)

Dernières nouvelles pour Rapport Therapeutics (NASDAQ:RAPP) Stock

Rapport Therapeutics

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

WIIM

Clorox shares are trading higher after the company reported better-than-expected Q4 adjusted EPS and sales.

Strategic acquisition jumpstarts WisdomTree's entry into the private asset markets, with a focus on a high-growth $3.5 trillion U.S. farmland market and adjacent verticals, including solar, AI data infrastructure and water
Day 1 accretive transaction that accelerates long-term earnings growth potential
WisdomTree, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WT#NYSE">WT</a>), a global financial innovator, announced today that it entered into a definitive agreement to acquire Ceres Partners, LLC, a leading U.S.-based alternative asset manager specializing in farmland investments. This transaction marks WisdomTree's entry into the private asset markets—starting with real estate and specifically farmland—and positions WisdomTree as a category leader. Additionally, the Ceres farmland platform benefits from opportunities in strategic adjacencies in demand for solar, AI data infrastructure and water that are expected to drive faster growth.
The acquisition delivers immediate scale and long-term upside, bringing approximately $1.85 billion in assets under management across approximately 545 U.S. farmland properties spanning 12 states, predominantly in the Midwest. Ceres has a strong track record of performance, having delivered a 10.3% net average annual total return since its inception in 2007—outperforming farmland benchmarks.
With farmland recognized as one of the largest and most underpenetrated real asset classes in the U.S., WisdomTree believes there is significant opportunity for growth. The asset class historically provides resilient, inflation-protected returns and is largely uncorrelated to traditional equity and bond markets. As demand accelerates for income-generating, inflation-hedged private investments, this transaction well positions WisdomTree to offer differentiated access on an institutional scale. Farmland prices and asset values rose in the U.S. in all but nine years since World War II, and Ceres represents a value-added platform in a category that has the fundamentals for greater advisor and institutional adoption.
"Farmland is one of the largest yet most underpenetrated real asset classes in the U.S., offering both scale and scarcity," said Jonathan Steinberg, WisdomTree Founder and CEO. "This acquisition expands our leadership in innovative, income-generating investment solutions, while strategically accelerating our entry into private asset markets with a high-quality, scalable platform. It reflects our commitment to delivering differentiated exposures that drive long-term value for clients and stockholders alike. This strategic acquisition now positions WisdomTree to capitalize on the most significant structural growth opportunities in wealth and asset management today: ETPs, private markets, managed models and tokenization."
Perry Vieth, Founder and CEO, Ceres Partners, said, "We are proud of Ceres' long-standing partnerships and legacy with farmers. Joining forces with WisdomTree marks an exciting new chapter for Ceres. For nearly two decades, we've built a differentiated farmland investment platform rooted in performance, operational expertise and a deep understanding of U.S. agricultural markets. This partnership brings product innovation, scale and distribution that will allow us to reach more investors seeking resilient, inflation-hedged and income-generating real assets. Together, we are uniquely positioned to capitalize on the next wave of growth in farmland —including solar, AI data infrastructure and water—with a shared commitment to innovation and long-term value creation."

WisdomTree Announces Acquisition Of Ceres Partners; Terms Not Disclosed

COIN

Coinbase shares are trading lower after the company reported worse-than-expected Q2 adjusted EPS and sales.

News

Dividends

Boise Cascade Increases Quarterly Dividend From $0.21 To $0.22

General

LGND

Orchestra BioMed Holdings, Inc. - Ordinary Shares

OBIO

Orchestra BioMed Secures  $70M In New Capital From Ligand Pharmaceuticals And Medtronic To Advance Its Late-Stage Partnered Cardiology Programs

SR Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRBK#NASDAQ">SRBK</a>) reported quarterly earnings of $0.10 per share. The company reported $7.500 million in sales this quarter.

Earnings

SRBK

SR Bancorp Q4 EPS $0.10, Sales $7.500M

AVNS

Avanos Medical Divests Hyaluronic Acid Product Line To Channel-Markers Medical; Avanos To Provide Transition Support Through 2025 End

Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) raises FY2025 GAAP EPS guidance from $(1.07)-$(1.00) to $(0.79)-$(0.72) vs $(1.03) analyst estimate..

Guidance

Workiva Raises FY2025 GAAP EPS Guidance from $(1.07)-$(1.00) to $(0.79)-$(0.72) vs $(1.03) Est

Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) raises FY2025 Adj EPS guidance from $1.02-$1.09 to $1.31-$1.38 vs $1.04 analyst estimate. Raises FY2025 sales outlook from $864.000 million-$868.000 million to $870.000 million-$873.000 million vs $866.326 million estimate.

Workiva Raises FY2025 Adj EPS Guidance from $1.02-$1.09 to $1.31-$1.38 vs $1.04 Est; Raises FY2025 Sales Guidance from $864.000M-$868.000M to $870.000M-$873.000M vs $866.326M Est

Automaker Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) wants investors and consumers to circle Aug. 11 on the calendar as the day when the company's position in <a href="https://www.benzinga.com/topic/electric-vehicle">the EV sector changes</a>.
What Happened: Ford reported<a href="https://www.benzinga.com/markets/earnings/25/07/46740005/ford-q2-earnings-revenue-eps-beat-estimates-shares-slide-as-automaker-warns-of-2-billion-tariff-headwind"> second-quarter financial results </a>this week, which included more details on the economic impacts that tariffs from the Donald Trump administration have had on the company.
While tariffs and the financial results were among the headlines, CEO Jim Farley provided another headline during the company's earnings call.
"August 11 will be a big day for all of us at Ford," Farley said during Wednesday's earnings call, as <a href="https://insideevs.com/news/767532/ford-ev-reveal-model-t-moment-august-11/">reported </a>by InsideEVs. "We will be in Kentucky to share more about our plans to design and build a breakthrough electric vehicle and a platform in the U.S."
According to the report, this could be Ford's secretive project that could be used for multiple EV models, including a compact SUV, small pickup truck, and an electric delivery vehicle.
"This is a Model T moment for us at Ford."
Farley's comments reference the early Ford vehicle that helped pioneer the mass production of low-cost vehicles. The presentation is likely to highlight more than one future model, according to comments from Farley.
The CEO said the event will be a "chance to bring a new family of vehicles to the world that offer incredible technology, efficiency, space, and features."
Read Also: <a href="https://www.benzinga.com/markets/tech/25/06/46020713/ford-says-upcoming-budget-ev-platform-will-rival-chinese-ev-prices-report">Ford Says Upcoming Budget EV Platform Will Rival Chinese EV Prices: Report</a>
Why It's Important: Ford's teaser comes as the Trump administration plans to eliminate federal EV tax credits later this year.
Ford is emphasizing growth from other vehicles, including hybrids and its gas-powered vehicles. It&#8217;s also canceling a three-row electric SUV that was in development.
Ford currently offers the Mustang Mach-E, F-150 Lightning and E-Transit van. The F-150 Lightning is the top-selling electric pickup truck in 2025. It <a href="https://www.benzinga.com/markets/large-cap/25/07/46475391/tesla-cybertruck-bet-not-paying-off-ford-gm-outsell-ev-giant">outsold models from</a> Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>).
General Motors, meanwhile, ramped up efforts in the EV space. Its pickup trucks saw strong unit growth for deliveries in the first half of 2025. 
Ford's event could see the unveiling of vehicles that will compete directly with GM models or Tesla models.
Ford's Model e EV segment had revenue of $2.4 billion in the second quarter, up 105% year-over-year. While the auto maker has lower EV sales in Q2, its hybrid deliveries rose.
Price Action: Ford stock trades at $11.02 on Thursday versus a 52-week trading range of $8.44 to $11.97.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46436042/ford-responds-to-trumps-ev-policy-shift-with-push-for-affordable-electric-models">Ford Responds To Trump&#8217;s EV Policy Shift With Push For Affordable Electric Models</a></li>
</ul>
Image: Shutterstock

Long Ideas

Management

Trading Ideas

TSLA

Ford CEO Teases Breakthrough EV: 'Model T Moment' For Company

Rocket Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>) sees Q3 sales of $1.600 billion-$1.750 billion vs $1.50 billion analyst estimate.

Rocket Companies Sees Q3 Sales $1.600B-$1.750B vs $1.50B Est

CDNA

CareDx Presents  Several High-Impact Studies And Digital Health Innovations By Independent Research Teams At The 2025 World Transplant Congress Demonstrating Advances In Artificial Intelligence, Predictive Diagnostics, Transplant Access, And Organ-Specific Innovation

Mettler-Toledo Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTD#NYSE">MTD</a>) raises FY2025 Adj EPS guidance from $41.25-$42.00 to $42.10-$42.60 vs $41.51 analyst estimate. Affirms FY2025 sales outlook from $3.911 billion-$3.949 billion to $3.911 billion-$3.949 billion vs $3.925 billion estimate.

Mettler-Toledo Intl Raises FY2025 Adj EPS Guidance from $41.25-$42.00 to $42.10-$42.60 vs $41.51 Est; Affirms FY2025 Sales Guidance of $3.911B-$3.949B vs $3.925B Est

Beazer Homes USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BZH#NYSE">BZH</a>) reported quarterly earnings of $0.28 per share which missed the analyst consensus estimate of $0.42 by 33.01 percent. This is a 68.18 percent decrease over earnings of $0.88 per share from the same period last year. The company reported quarterly sales of $545.367 million which missed the analyst consensus estimate of $559.046 million by 2.45 percent. This is a 8.45 percent decrease over sales of $595.682 million the same period last year.

Earnings Misses

Beazer Homes USA Q3 Adj. EPS $0.28 Misses $0.42 Estimate, Sales $545.367M Miss $559.046M Estimate

Reddit Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) reported financial results for the second quarter on after the bell. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/07/b46774120/reddit-announces-second-quarter-2025-results">of the report</a>.
RDDT stock is on the move, climbing higher. <a href="https://www.benzinga.com/quote/RDDT" target="_blank" rel="noreferrer noopener">Check the latest price here.</a>
Q2 Earnings: Reddit reported second-quarter revenue of $499.6 million, beating the&nbsp;<a href="https://www.benzinga.com/quote/RDDT/earnings" target="_blank" rel="noreferrer noopener">consensus estimate</a>&nbsp;of $424.73 million, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.&nbsp;The company reported second-quarter earnings of 48 cents per share, beating analyst estimates of 19 cents per share.
Total revenue climbed 78% on a year-over-year basis as daily active unique (DAUq) users increased 21% year-over-year to 110.4 million. U.S. DAUq grew 11% year-over-year and International DAUq increased 32%. 
Reddit generated operating cash flow of $111 million and free cash flow of $111 million in the quarter. The company ended the quarter with $2.06 billion in cash and cash equivalents.
&#8220;With 20+ years of conversations across 100,000+ communities, Reddit is the internet's largest archive of authentic dialogue, powering how people learn and decide and helping brands understand their audience and build better products,&#8221; the company said in a letter to shareholders.
&#8220;This same depth and breadth of human conversation also powers AI and leading large language models, making Reddit foundational to the next generation of technology.&#8221;
Guidance:&nbsp;Reddit expects third-quarter revenue to be in the range of $535 million to $545 million versus estimates of $471.49 million. The company anticipates third-quarter adjusted EBITDA of $185 million to $195 million.
Reddit&#8217;s management team will discuss the quarter on an earnings call with investors and analysts at 5 p.m. ET.
RDDT Price Action:&nbsp;<a href="http://benzinga.com/quote/rddt" target="_blank" rel="noreferrer noopener">Reddit shares</a>&nbsp;were up 15.03% in after-hours, trading at $184.72 at the time of publication on Thursday, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46653719/mark-cuban-urges-trumps-ai-advisor-to-make-it-illegal-for-llms-to-serve-ads-reminds-of-social-medias-algorithm-lessons">Mark Cuban Urges Trump&#8217;s AI Advisor To &#8216;Make It Illegal&#8217; For LLMs To Serve Ads, Reminds Of Social Media&#8217;s Algorithm Lessons</a></li>
</ul>
Photo: Henry Franklin/Shutterstock.com

Social Media

After-Hours Center

Movers

RDDT

Reddit Q2 Earnings: Revenue Beat, EPS Beat, Strong Guidance Drives Shares Higher

Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) is looking for Q3 GAAP EPS of $(0.18)-$(0.14) vs $(0.21) analyst estimate..

Workiva Sees Q3 GAAP EPS $(0.18)-$(0.14) vs $(0.21) Est

BBAI

BigBear.ai Collaborates With DEFCON AI To Transform Force Readiness And Joint Logistics Capabilities.

Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) is looking for Q3 Adj EPS of $0.37-$0.41 vs $0.33 analyst estimate. sees sales of $218.000 million-$220.000 million vs $218.198 million analyst estimate.

Workiva Sees Q3 Adj EPS $0.37-$0.41 vs $0.33 Est; Sees Sales $218.000M-$220.000M vs $218.198M Est

AAPL

'Apple's Iphone Sales Blow Past Estimates As Some Customers Raced To Beat Tariffs'

Mettler-Toledo Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTD#NYSE">MTD</a>) is looking for Q3 Adj EPS of $10.55-$10.75 vs $10.47 analyst estimate. sees sales of $983.171 million-$992.716 million vs $985.410 million analyst estimate.

Mettler-Toledo Intl Sees Q3 Adj EPS $10.55-$10.75 vs $10.47 Est; Sees Sales $983.171M-$992.716M vs $985.410M Est

Health Care

Press Releases

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development

Comments

Rapport Therapeutics

Actualités

Dernières nouvelles pour Rapport Therapeutics (NASDAQ:RAPP) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL